Randomized, Double-Blind Study of the Pharmacokinetics and Safety of Palivizumab Liquid Formulation Compared with Lyophilized Formulation

OBJECTIVE: To assess the pharmacokinetics and safety of liquid palivizumab compared with lyophilized palivizumab. METHODS: This phase 2, randomized, double-blind crossover study included premature infants aged ≤6 months born ≤35 weeks gestational age. Patients were randomized in a 1:1 ratio to recei...

Descripción completa

Detalles Bibliográficos
Autores principales: Robbie, Gabriel J., Makari, Doris, Harris, Brian, Losonsky, Genevieve A., Jafri, Hasan S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4269619/
https://www.ncbi.nlm.nih.gov/pubmed/25269648
http://dx.doi.org/10.1007/s40121-014-0042-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4269619/
https://www.ncbi.nlm.nih.gov/pubmed/25269648
http://dx.doi.org/10.1007/s40121-014-0042-x

Ejemplares similares